Specific collagen peptide compositions for next-gen targeted solutions
Did you know there’s still more to discover about collagen? Our scientists have been delving into the unknown and decoding the collagen language to uncover new modes of action. The result is NEXTIDA, a range of newly discovered specific collagen peptide compositions that deliver targeted health benefits, acting as a GPS to naturally guide the body back to balance. Built and backed by science, the Nextida platform opens the door to the next generation of unique targeted solutions.
Guiding the body back to balance naturally with Nextida
Nextida, an innovative platform of specific collagen peptide compositions, delivers targeted health benefits that go beyond those traditionally associated with collagen. Discovered through cutting-edge research into the collagen molecule, Nextida harnesses the body’s natural use of bioactive peptides to restore balance. Each specific collagen peptide composition in the Nextida range can trigger new modes of action, resulting in unique targeted health benefits.
Nextida operates like GPS: collagen is a language, and different compositions communicate different messages to the body. The right collagen peptide composition is like a set of exact coordinates, telling the body how and where to get back to balance.
How our scientists are decoding the collagen language
While collagen’s skin, bone, and joint benefits are well-documented in numerous scientific studies, we know there’s more to unlock. That’s why Rousselot is going beyond the known, decoding the hidden messages in the collagen molecule and uncovering new modes of action that can lead to new targeted health benefits.
By exploring the link between imbalances in the body and specific collagen peptide compositions, our scientists are putting together a library of compositions that can naturally guide the body back to balance. By testing how each one affects the body, the team selects the most effective candidate for further trials. The compositions that complete this process are ready to be launched as a product brand within the Nextida range, with the first product set for release later this year.
Targeting glucose control with Nextida’s first launch
The first commercialized collagen peptide composition to be launched from the Nextida platform is Nextida.GC, a natural solution for managing glucose metabolism. Nextida.GC has been shown in pre-clinical and clinical studies to reduce the post-meal blood sugar spike, in a natural way. Nextida.GC will be launched at this year’s SupplySide West in Las Vegas, taking place between October 28 and 31. For ‘Precision where it matters’, find the exact location to meet us with the GPS coordinates below.
Nextida.GC underscores the potential of the Nextida platform to uncover new modes of action and deliver targeted benefits that go further than those traditionally attributed to collagen peptides. More collagen peptide compositions with targeted health benefits are currently being discovered, developed, and scheduled for future release.
Be the first to learn about the Nextida.GC study results and when it will be available in your region!
Stay up to date with Nextida
With an expanding library of specific collagen peptide compositions, Nextida unlocks new possibilities. It’s supported by in-depth scientific research and offers both application versatility and clinically demonstrated safety and efficacy. Altogether, Nextida lets manufacturers deliver next-gen solutions to consumers and open up a new market opportunity.
Stay up to date by exploring Nextida.com, a new webpage featuring a brand-new video, our on-demand webinar, and much more…